Biliary tract cancers in olmsted county, Minnesota, 1976-2008

American Journal of Gastroenterology

Volumn 107, Issue 8, 2012, Pages 1256-1262

  Yang, Ju Dong ^a   Kim, Bohyun ^b   Sanderson, Schuyler O ^b   Sauver, Jennifer St ^b   Yawn, Barbara P ^c   Larson, Joseph J ^a   Therneau, Terry M ^a   Roberts, Lewis R ^a   Gores, Gregory J ^a   Kim, W Ray ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c OLMSTED MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CANCER INCIDENCE; CANCER SURVIVAL; FEMALE; GALLBLADDER CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES;

AGED; BILE DUCT NEOPLASMS; BILIARY TRACT NEOPLASMS; CHOLANGIOCARCINOMA; CHOLECYSTECTOMY; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MINNESOTA; PROGNOSIS; SURVIVAL RATE;

EID: 84864617101     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.173     Document Type: Article

References (25)

1. de Groen PC, Gores GJ, LaRusso NF et al. Biliary tract cancers. N Engl J Med 1999; 341: 1368-78.
2. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-7. (Pubitemid 32496970)
3. Shaib YH, Davila JA, McGlynn K et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 40: 472-7. (Pubitemid 38230849)
4. Welzel TM, McGlynn KA, Hsing AW et al. Impact of classifi cation of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra-and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006; 98: 873-5. (Pubitemid 43923444)
5. West J, Wood H, Logan RF et al. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 2006; 94: 1751-8. (Pubitemid 43924943)
6. Khan SA, Taylor-Robinson SD, Toledano MB et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002; 37: 806-13. (Pubitemid 35404220)
7. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002; 2: 10.
8. Jepsen P, Vilstrup H, Tarone RE et al. Incidence rates of intra-and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002. J Natl Cancer Inst 2007; 99: 895-7. (Pubitemid 47073512)
9. Rosen CB, Heimbach JK, Gores GJ. Surgery for cholangiocarcinoma: the role of liver transplantation. HPB (Oxford) 2008; 10: 186-9. (Pubitemid 352016246)
10. Gusani NJ, Balaa FK, Steel JL et al. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J Gastrointest Surg 2008; 12: 129-37.
11. Park SY, Kim JH, Yoon HJ et al. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma. Clin Radiol 2011; 66: 322-8.
12. Valle J, Wasan H, Palmer DH et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362: 1273-81.
13. Melton III LJ. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: 266-74.
14. Connolly DC, Oxman HA, Nobrega FT et al. Coronary heart disease in residents of Rochester, Minnesota, 1950-1975. I. Background and study design. Mayo Clin Proc 1981; 56: 661-4. (Pubitemid 12254383)
15. St Sauver JL, Grossardt BR, Yawn BP et al. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol 2011; 173: 1059-68.
16. Moreno Luna LE, Kipp B, Halling KC et al. Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 2006; 131: 1064-72. (Pubitemid 44498705)
17. Shaib YH, El-Serag HB, Davila JA et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005; 128: 620-6. (Pubitemid 40585364)
18. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995; 75: 171-90.
19. Kiran RP, Pokala N, Dudrick SJ. Incidence pattern and survival for gallbladder cancer over three decades-an analysis of 10301 patients. Ann Surg Oncol 2007; 14: 827-32. (Pubitemid 46175333)
20. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology 2009; 136: 1134-44.
21. Diehl AK, Beral V. Cholecystectomy and changing mortality from gallbladder cancer. Lancet 1981; 2: 187-9. (Pubitemid 11085411)
22. Wood R, Fraser LA, Brewster DH et al. Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-1998. Eur J Cancer 2003; 39: 2080-6. (Pubitemid 37297765)
23. Maringhini A, Moreau JA, Melton III LJ et al. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An epidemiologic study in Rochester, Minnesota. Ann Intern Med 1987; 107: 30-5. (Pubitemid 17098633)
24. Ransohoff DF, Gracie WA, Wolfenson LB et al. Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival. Ann Intern Med 1983; 99: 199-204. (Pubitemid 13041472)
25. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88: 165-75. (Pubitemid 32142701)